Nuvectis Pharma, Inc. (NVCT) is listed on NASDAQ in the Manufacturing sector. This page tracks real-time NVCT price, technical indicators including RSI, MACD, and the 52-week range, plus fundamentals, earnings history, and recent insider trading activity.
Technical Analysis
RSI (14) 47.9 Neutral
Market Cap $634.0M
Volume 42.6K
Fundamentals — 10-Q Q2 2026
Revenue --
Net Income $-13.1M
EPS $-0.56
P/E Ratio -34.8x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Mosseri Marlio Charles | 10% Owner | Buy | 50,000 | $18.32 | $916,000 | 2026 Jun 30 |
| Bentsur Ron | Chairman & CEO | Buy | 12,500 | $20.00 | $250,000 | 2026 Jun 30 |
| Bentsur Ron | Chairman & CEO | Buy | 5,000 | $5.72 | $28,600 | 2025 Nov 5 |
| Kaplan Matthew L. | Director | Buy | 11,000 | $5.84 | $64,240 | 2025 Nov 5 |
| Sanchez Juan | Director | Buy | 13,000 | $5.79 | $75,270 | 2025 Nov 5 |
| Mosseri Marlio Charles | 10% Owner | Buy | 154,770 | $6.18 | $957,083 | 2025 Oct 27 |
| Mosseri Marlio Charles | 10% Owner | Buy | 5,603 | $7.99 | $44,768 | 2025 Jun 20 |
| Mosseri Marlio Charles | 10% Owner | Buy | 33,442 | $8.06 | $269,532 | 2025 Jun 18 |
| Mosseri Marlio Charles | 10% Owner | Buy | 21,167 | $8.11 | $171,664 | 2025 May 12 |
| Mosseri Marlio Charles | 10% Owner | Buy | 27,411 | $8.60 | $235,647 | 2025 May 8 |
| Mosseri Marlio Charles | 10% Owner | Buy | 240,000 | $5.00 | $1.2M | 2025 Feb 7 |
| Bentsur Ron | Chairman & CEO | Buy | 4,500 | $4.65 | $20,925 | 2024 Dec 24 |
| Mosseri Marlio Charles | 10% Owner | Buy | 17,000 | $4.70 | $79,900 | 2024 Dec 13 |
| Poradosu Enrique | Chief Science & Business Off | Buy | 2,000 | $4.99 | $9,980 | 2024 Nov 19 |
| Bentsur Ron | Chairman & CEO | Buy | 20,000 | $4.92 | $98,400 | 2024 Nov 15 |
| Carson Michael J. | Vice President, Finance | Sell | 2,755 | $8.16 | $22,481 | 2024 Nov 7 |
| Bentsur Ron | Chairman & CEO | Buy | 1,940 | $6.74 | $13,076 | 2024 May 14 |
| Bentsur Ron | Chairman & CEO | Buy | 2,000 | $6.40 | $12,800 | 2024 May 10 |
| Shemesh Shay | Chief Dev. & Ops. Officer | Buy | 1,113 | $6.32 | $7,034 | 2024 May 10 |
| Poradosu Enrique | Chief Science & Business Off | Buy | 500 | $6.29 | $3,145 | 2024 May 10 |
Take NVCT further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put NVCT in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Nuvectis Pharma, Inc. next reports.
Set alerts on NVCT
Get notified when Nuvectis Pharma, Inc. hits your price targets or technical conditions are met.
Get Started Free